Dr. Robert A. Brodsky, MD

Dr. Brodsky practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Brodsky's NPI, 1194783712, was assigned on May 3, 2006. Dr. Brodsky graduated from Drexel University College Of Medicine in 1989. Dr. Brodsky holds Maryland license D45343.

Dr. Brodsky's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Brodsky's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Brodsky is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Brodsky to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brodsky practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Brodsky's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Brodsky is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Brodsky's licenses on file in 2 states: Maryland and Tennessee.

Dmand AI lists chronic anemia and purpura and thrombocytopenia among the conditions Dr. Brodsky treats.

CMS data shows 295 Medicare services from Dr. Brodsky across 8 procedure codes in 2024, for 153 Medicare patients. Medicare paid $23,310 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 153 Medicare patients who saw Dr. Brodsky in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 24% are also on Medicaid. Their average risk score is 3.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brodsky's median patient age at 67, with 56% women.

In 2024, Dr. Brodsky wrote 137 Medicare Part D claims for 15 patients. 75% of them were for generic drugs. CMS names the drug for 73 of them, across 5 drugs with 11 or more claims each, at $13,273 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Brodsky for performance year 2024, reported as part of a group.

Dmand AI links 261 papers to Dr. Brodsky, published from 2005 to 2025. 2017 was the busiest year, with 17. The most frequent topics are Hemoglobinuria, Paroxysmal, Cyclophosphamide and Bone Marrow Transplantation. Dr. Brodsky has published most often in Blood. Dr. Brodsky's most frequent co-authors are Richard Ambinder, MD, Leonido Luznik, MD and Amy Elizabeth Dezern, MD.

Dmand AI links Dr. Brodsky to 7 clinical trials, 4 of them phase 2 studies. Conditions studied include Anemia, Aplastic, Hemoglobinuria, Paroxysmal and Anemia, Hemolytic. Alexion Pharmaceuticals, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Brodsky that name 1 trial.

CMS Open Payments shows 29 general payments to Dr. Brodsky from 3 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 60% of the total. Alexion Pharmaceuticals, Inc. paid the most, $26,980. It also lists 2 research payments totaling $86,250 in 2019, naming 1 clinical trial.

Dmand AI lists 5 awards for Dr. Brodsky, most recently Top Doctors:Baltimore Area in 2024.

Dr. Brodsky graduated from Drexel University College Of Medicine in 1989. Dr. Brodsky is a member of ASH.

Dr. Brodsky is in network with 8 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.